[Iris-fixated intraocular lenses: reinforced monitoring].
In 1986, the concept of the claw lens was applied to correct myopia in phakic patients. Since then, progress has made iris-fixated phakic intraocular lenses (IOL) relatively safe, predictable, and effective for the correction of myopia, hyperopia, and astigmatism. All these models have undergone a series of design improvements to prevent complications. Despite having excellent refractive results, the principal risk is a potential progressive endothelial cell loss. Many authors have presented encouraging results. Phakic iris-fixated IOL surgery is a potentially reversible procedure, but the surgeon cannot rule out the possibility of complications. Therefore, long-term follow-up is mandatory.
Fournié
P
P
Service d'Ophtalmologie, CHU Toulouse, Hôpital Purpan, France. fournie.p@chu-toulouse.fr
Malecaze
F
F
D001251:Astigmatism / Q000601:surgery; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004728:Endothelium, Corneal / Q000473:pathology; D006801:Humans; D006956:Hyperopia / Q000601:surgery; D007498:Iris / Q000293:injuries; D019654:Lens Implantation, Intraocular / Q000009:adverse effects / Q000379:methods*; D009216:Myopia / Q000601:surgery; D009798:Ocular Hypertension / Q000209:etiology; D054120:Phakic Intraocular Lenses; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011358:Product Surveillance, Postmarketing; D013536:Suture Techniques; D016896:Treatment Outcome